• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮中乙酰化表型的正态分布。

Normal distribution of acetylation phenotypes in systemic lupus erythematosus.

作者信息

Vansant J, Woosley R L, John J T, Sergent J S

出版信息

Arthritis Rheum. 1978 Mar;21(2):192-5. doi: 10.1002/art.1780210203.

DOI:10.1002/art.1780210203
PMID:637885
Abstract

Previous reports have indicated that idiopathic systemic lupus erythematosus (SLE), like drug-induced lupus, is more frequent in "slow" hepatic acetylators. Using dapsone acetylation rate to determine phenotypes, we found that of the 18 SLE patients studied, 9 were fast acetylators, 8 were slow, and 1 was indeterminate. This result (53% fast) is similar to acetylator phenotypes in our normal controls (50% fast) and in the population at large (52%).

摘要

先前的报告指出,特发性系统性红斑狼疮(SLE)与药物性狼疮一样,在“慢”型肝脏乙酰化酶人群中更为常见。通过使用氨苯砜乙酰化速率来确定表型,我们发现,在所研究的18例SLE患者中,9例为快乙酰化酶型,8例为慢乙酰化酶型,1例不确定。这一结果(53%为快乙酰化酶型)与我们正常对照人群(50%为快乙酰化酶型)以及总体人群(52%)的乙酰化酶表型相似。

相似文献

1
Normal distribution of acetylation phenotypes in systemic lupus erythematosus.系统性红斑狼疮中乙酰化表型的正态分布。
Arthritis Rheum. 1978 Mar;21(2):192-5. doi: 10.1002/art.1780210203.
2
Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.药物乙酰化表型与自发性系统性红斑狼疮的发生无关。
Arthritis Rheum. 1979 Jul;22(7):777-80. doi: 10.1002/art.1780220714.
3
Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.伊拉克系统性红斑狼疮患者的乙酰化酶表型
East Mediterr Health J. 2005 Sep-Nov;11(5-6):1003-8.
4
Acetylator phenotype in idiopathic systemic lupus erythematosus.特发性系统性红斑狼疮中的乙酰化酶表型
Arthritis Rheum. 1980 May;23(5):569-73. doi: 10.1002/art.1780230508.
5
Drug acetylation and expression of lupus erythematosus.药物乙酰化与红斑狼疮的表达
Eur J Clin Pharmacol. 1985;28(4):387-90. doi: 10.1007/BF00544355.
6
Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.乙酰化酶表型与系统性红斑狼疮之间缺乏关联的进一步证据。
Arthritis Rheum. 1986 Apr;29(4):508-14. doi: 10.1002/art.1780290408.
7
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
8
Acetylator phenotype and lupus erythematosus.乙酰化酶表型与红斑狼疮
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
9
Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.日本系统性红斑狼疮患者的乙酰化表型及异烟肼的代谢情况
Arthritis Rheum. 1981 Oct;24(10):1245-54. doi: 10.1002/art.1780241004.
10
The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese.东南亚人群中乙酰化酶表型与特发性系统性红斑狼疮之间不存在关联:一项针对印度人、马来人和马来西亚华人的研究。
Br J Rheumatol. 1990 Dec;29(6):462-4. doi: 10.1093/rheumatology/29.6.462.

引用本文的文献

1
Plaintiffs, defendants, lawyers, and lawyers: facts and rumors about silicone.原告、被告、律师以及律师们:关于硅胶的事实与传闻。
West J Med. 1997 Sep;167(3):182-3.
2
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
3
Acetylator phenotype and lupus erythematosus.
乙酰化酶表型与红斑狼疮
Clin Pharmacokinet. 1981 Mar-Apr;6(2):118-34. doi: 10.2165/00003088-198106020-00003.
4
Survey of the human acetylator polymorphism in spontaneous disorders.自发性疾病中人类乙酰化多态性的调查。
J Med Genet. 1984 Aug;21(4):243-53. doi: 10.1136/jmg.21.4.243.
5
Drug acetylation and expression of lupus erythematosus.药物乙酰化与红斑狼疮的表达
Eur J Clin Pharmacol. 1985;28(4):387-90. doi: 10.1007/BF00544355.
6
Acetylator polymorphism in discoid lupus erythematosus.盘状红斑狼疮中的乙酰化酶多态性
Eur J Clin Pharmacol. 1988;34(3):307-8. doi: 10.1007/BF00540961.
7
Genetically determined variability in acetylation and oxidation. Therapeutic implications.乙酰化和氧化的基因决定变异性。治疗意义。
Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003.